In view of the importance of picolinic acid (Pa) in preventing cell growth and arresting cell cycle, attempts were made to design, synthesize and characterize two new Pa based tetradentate ligands (DPPTR and DPPTY) with a modified procedure. The procedure reported here avoids by-products and provides better yield and purity.
Introduction
Synthesis of ligands with peptide bond has attracted lot of attention due to their importance in biological systems. Many reagents were used to get the desired peptides [1] - [5] . Among them DCC (N,N'-dicyclohexylcarbodiimide), EDCI (3-(Ethyliminomethyleneamino)-N,N-dimethylpropan-1-amine), HOBT (1-Hydroxybenzotriazole) and HATU (1-[Bis(dimethylamino)methylene]-1H-1,2,3-triazolo [4,5-b ]pyridinium 3-oxid hexafluorophosphate) were extensively used [6] - [11] . However, with DCC and EDCI-HOBT, there is a possibility of by-product formation, reduction in the yield and makes purification difficult. With DCC, multiple by-products like anhydride, urea and N-acylurea were formed [12] [13] . To avoid this HATU was used earlier for the synthesis of simple peptides [14] [15] . In view of this, We adopted a modified procedure employing HATU and DIEA (N,N-Diisopropylethylamine) for the synthesis of tetradentate ligand involving peptide bond. The base (DIEA) has an advantage due to the presence of an isopropyl group which helps in increasing the basicity on N-atom and facili-tates the proton abstraction from the acid. Since Pa and their derivatives are known to prevent the cell growth and arrest the cell cycle [16] , it was thought important to design, synthesize and characterize two new Picolinic acid based tetradentate ligands, N-(3-(1H-indol-3-yl)-1-oxo-1-(pyridine-2-yl methylamino)propan-2-yl) picolinamide (DPPTR) and N-3-(4-hydroxyphenyl)-1-oxo-1-(pyridine-2-ylmethylamino) propan-2-yl) picolinamide (DPPTY) using HATU and DIEA. The synthesis of ligands involves three steps (Scheme 1). The intermediates and final ligands were isolated and characterized. The results show that the yields for the intermediates are >90% and for final ligands > 80% with good purity.
Results and Discussion

DPTR-I/DPTY-I
The ESI-Mass spectra of DPTR-I (Figure 1 The mechanism involves, 1) Proton abstraction occurs from Pa followed by the addition of carboxylate anion (-Coo − ) to the electron deficient carbon atom of HATU. This results in the formation of new C-O bond.
2) The resulting anion reacts with the newly formed activated carboxylic acid derived from intermediate to form an OBt activated ester.
3) The amine reacts with the OBt activated ester to form the amide product. Similar mechanism was proposed earlier for the formation of amide bond [19] - [21] .
DPTR-II/DPTY-II
The ESI-Mass spectra of DPTR-II ( The general mechanism for the de-esterification by base involves a series of equilibria. The hydroxide anion adds to the carbonyl group of the ester. The direct products are a carboxylic acid salt and an alcohol. To convert the salt to the corresponding carboxylic acid, acidic workup of the product mixture was performed [23] .
Final Ligands: DPPTR/DPPTY
The ESI-Mass spectra of DPPTR- (Figure 11) shows m/z peak at 400 indicating that the DPPTR molecular ion species appeared as [M + H] + and for DPPTY (Figure 12 , SM) the mass spectra shows a peak at 377 suggesting that the DPPTY molecular ion species appeared as [M + H] 34 (m, 2H), 3.06 -2.99 (m, 2H) .
IR spectra of DPPTR/DPPTY DPPTR (Figure 15 
Figure 14.
1 H-NMR spectra of DPPTY. The mechanism for the formation of final ligands is similar to that described for the formation of DPTR-I/ DPTY-I except that the starting materials are different.
Conclusion
Two new tetradentate ligands involving peptide bond were synthesized with a modified procedure and characterized. The procedure is simple and avoids by-products and results in better yields. Since small molecular bio-ligands containing peptide bond are known to play an important role as biomimetics, construction of such mimics can lead to a better understanding of the biological complexity at a molecular level. Therefore, the procedure described here will provide an opportunity to synthesize new small molecules.
Experimental Section
Material and Methods
Picolinic acid, Tryptophan-methyl ester, Tyrosine-methyl ester, picolylamine and LiOH•H 2 O are obtained from sigma chemical company (99% purity), USA. HATU and solvents (DIEA, methanol, Ethylacetate, n-Hexane and dimethylformamide) were purchased from Merck, India and were of analar grade. The chemicals were used as supplied. The TLC silica gel plates (60 F 254 ) were obtained from Merck. Infrared spectra were recorded on a Perkin-Elmer FT-IR spectrometer in the range of 4000 -750 cm −1 using Methanol as solvent. ESI mass spectra for the ligands were recorded on a Quattro Lc (Micro mass, Manchester, UK) triple quadruple mass spectrometer with Mass Lynx software and Shimadzu, model LC-MS; 8030. The 1 H-NMR spectra were recorded on a Bruker Biospin and Avance-III 400 MHz Fourier Transform Digital NMR Spectrometer, Switzerland using DMSO as solvent and TMS as the internal standard. The melting points were recorded on a cintex melting point instrument and are uncorrected. All reactions were carried under N 2 atmosphere.
Synthesis of Peptides
The synthesis of peptides involves three steps (Scheme 1). The following procedure was adopted for the synthesis.
DPPTR:
For the synthesis of DPPTR, 2-picolinic acid (0.2 g, 1.62 mmol) was dissolved in dry DMF (10 mL) and HATU (0.74 g, 1.95 mmol) and DIEA (0.62 g, 4.86 mmol) were added. The solution was cooled to 0˚C. The solution was stirred for 30 min followed by the addition of Tryptophan-methyl ester (0.62 g, 2.43 mmol). The mixture was warmed to room temperature and the stirring continued for another 12 h. After the workup, the solvent was removed under reduced pressure and the remaining solid was washed with petroleum ether to afford the compound, DPTR-I (yield: 0.481 g, 93%). In the second step, the protected methyl ester (OMe) was removed by saponification using LiOH in MeOH to get DPTR-II. It was purified by column chromatography (yield: 0.419 g, 91%). Finally, DPTR-II (0.42 g, 1.35 mmol) was dissolved in dry DMF (10 ml) and HATU (0.61 g, 1.62 mmol) and DIEA (0.52 g, 4.05 mmol) were added and the mixture was cooled to 0˚C. The solution was stirred for 30 min and the picolylamine (0.22 g, 2.03 mmol) was added. The mixture was warmed to room temperature and stirred for another 12 h. After the workup, the solvent was removed under reduced pressure. The residue was purified by column chromatography on silica gel (eluent: hexane/ethyl acetate) to afford the compound DPPTR (yield: 0.459 g, 85%). The DPPTY was synthesized as per the procedure described in SM.
